ロード中...
Rapamycin treatment attenuates age-associated periodontitis in mice
Interventions that target biological mechanisms of aging have great potential to enhance quality of life by delaying morbidity and mortality. The FDA-approved drug rapamycin is a compelling candidate for such an intervention. In a previous study, it was reported that 3 months of rapamycin treatment...
保存先:
| 出版年: | GeroScience |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5636779/ https://ncbi.nlm.nih.gov/pubmed/28889220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-017-9994-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|